KEGG   DRUG: Doravirine and islatravir
Entry
D13246            Mixture   Drug                                   
Name
Doravirine and islatravir;
Idvynso (TN)
Component
Doravirine [DR:D10624], (Islatravir hydrate [DR:D11914] | Islatravir [DR:D11432])
Class
Metabolizing enzyme substrate
 DG01633  CYP3A/CYP3A4 substrate
  DG02913  CYP3A4 substrate
Remark
Therapeutic category: 6250
Product: D13246<JP>
Efficacy
Antiviral
Target
HIV-1 reverse transcriptase [KO:K24802]
Metabolism
Enzyme: CYP3A4 [HSA:1576]
Interaction
Brite
Therapeutic category of drugs in Japan [BR:br08301]
 6  Agents against pathologic organisms and parasites
  62  Chemotherapeutics
   625  Antivirals
    6250  Antivirals
     D13246  Doravirine and islatravir
Drug groups [BR:br08330]
 Metabolizing enzyme substrate
  DG01633  CYP3A/CYP3A4 substrate
   DG02913  CYP3A4 substrate
    D13246  Doravirine and islatravir
Antimicrobials [BR:br08307]
 Antivirals
  Genome replication inhibitor
   HIV reverse transcriptase inhibitor
    D13246  Doravirine and islatravir <JP>
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D13246
Drug metabolizing enzymes and transporters [br08309.html]
 Drug metabolizing enzymes
  D13246
Other DBs
PubChem: 527701149
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system